Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
PACIRA PHARMACEUTICALS INC. via VENN STRATEGIES
2026 · third_quarter · Q3
Improving access to non-opioid approaches to pain management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PACIRA PHARMACEUTICALS INC. via VENN STRATEGIES
2026 · second_quarter · Q2
Source: Senate LDA
Improving access to non-opioid approaches to pain management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMPLOYEE-OWNED S CORPORATIONS OF AMERICA via VENN STRATEGIES
2024 · third_quarter · Q3
Legislation and other proposed policy change impacting S Corporation ESOPs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of